A Phase 1 clinical trial to evaluate the safety and tolerability of CLZ-2002 for the treatment of patients with Charcot-Marie-Tooth disease type 1. [PDF]
Stem Cells Transl MedKim H +5 more
europepmc +1 more source
<i>DNM2</i>-Charcot-Marie-Tooth neuropathy stems from disrupted Schwann cell function and shows limited therapeutic reversibility. [PDF]
Brain CommunGoret M, Arbogast T, Laporte J.
europepmc +1 more source
Complex Charcot Spine Reconstruction in a Young Paraplegic Patient: A Case Report. [PDF]
CureusKrall T +4 more
europepmc +1 more source
Hexapod-assisted limb salvage after talectomy: outcomes of tibiocalcaneal arthrodesis using the TL-hex system. [PDF]
Arch Orthop Trauma SurgGuerrero Serrano JA +4 more
europepmc +1 more source
A Case Report of a Novel Myelin Protein Zero (<i>MPZ</i>) Pathogenic Variant in Charcot-Marie-Tooth Disease Combined With Type 2 Diabetes. [PDF]
Case Rep GenetXia L +6 more
europepmc +1 more source
Pharmacological treatment for Charcot neuroarthropathy: a systematic review. [PDF]
BMC Musculoskelet DisordLiu L +5 more
europepmc +1 more source
Morbidity and Mortality Rates in People with Diabetes Mellitus With an Active Charcot's Neuro-Osteoarthropathy: A 15-Year Single-Center Retrospective Analysis. [PDF]
Diabetes TherPatel D +3 more
europepmc +1 more source
Pathogenic <i>LRSAM1</i> RING Domain Variants Disrupt Intracellular Protein Localization in Charcot-Marie-Tooth Disease Type 2P. [PDF]
Hum MutatHakonen JE +10 more
europepmc +1 more source
Vacuum Scaling Drainage in the Treatment of Infected Elbow Charcot Neuroarthropathy: A Case Report and Literature Review. [PDF]
Am J Case RepYang H.
europepmc +1 more source
Radiographic and Clinical Outcomes in Patients With Charcot Neuroarthropathy Undergoing 1-Stage Screw Arthrodesis: 1-Year Follow-up. [PDF]
Foot Ankle OrthopHernádez Bermúdez T +2 more
europepmc +1 more source